Difference between revisions of "Leadership"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
[unchecked revision][unchecked revision]
Line 10: Line 10:
  
  
[[File:Greg Corboy photo1.jpg|center|thumb|Greg Corboy, PhD]]
+
[[File:Greg Corboy photo1.jpg|center|thumb|Greg Corboy, PhDLabPlus Auckland City Hospital (Auckland, New Zealand), School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); '''Co-Associate Editor CCGA [Lymphoma Section]''']]
 
 
Picture coming soon:
 
Greg Corboy, PhD
 
LabPlus Auckland City Hospital (Auckland, New Zealand)
 
School of Clinical Sciences, Monash University (Melbourne, Australia)
 
Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia)
 
'''Co-Associate Editor CCGA [Lymphoma Section]'''
 

Revision as of 17:20, 18 June 2020

Meet your editors! We welcome questions and your participation in the CCGA.

Jennelle C. Hodge, PhD, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; Editor-in-Chief CCGA, Associate Editor CCGA [AML Section]
Fabiola-Quintero-Rivera, MD, Professor, Department of Pathology and Laboratory Medicine, University of California Los Angeles; Associate Editor CCGA [MDS/MPN Section]
Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; Associate Editor CCGA [ALL Section]
Snehal Patel, MD, PhD; Co-Associate Editor CCGA [Lymphoma Section]


Greg Corboy, PhDLabPlus Auckland City Hospital (Auckland, New Zealand), School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); Co-Associate Editor CCGA [Lymphoma Section]